Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Grant or award Chief Scientific Officer acquired 76,800 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. 144 Insider Sale of Securities
  7. 8-K/A Event Executive or director change · Regulation FD disclosure
  8. 8-K Event Executive or director change · Regulation FD disclosure
  9. 144 Insider Sale of Securities
  10. 8-K Event Executive or director change
  11. 4 Grant or award Director acquired 2,474 shares (grant or award)
  12. 4 Grant or award Director acquired 2,023 shares (grant or award)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 1,837 shares (to pay taxes)
  14. 4 Shares withheld for taxes President & CEO gave up 3,329 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Business Officer gave up 661 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 661 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Scientific Officer gave up 661 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief People Officer gave up 661 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Legal Officer gave up 661 shares (to pay taxes)
  20. 4 Derivatives Options or other derivatives

Page 9 of 28 · 549 filings